You are viewing an incomplete version of our website. Please click to reload the website as full version.

ENOS antibody (Nitric Oxide Synthase 3 (Endothelial Cell)) (pSer1177)

Details for Product anti-NOS3 Antibody No. ABIN362157, Supplier: Log in to see
Antigen
  • 2310065A03Rik
  • cNOS
  • EC-NOS
  • ecNOS
  • ECNOS
  • eNOS
  • eNos
  • ENOS
  • NOS
  • Nos-3
  • NOS3
  • NOSIII
Alternatives
anti-Human ENOS antibody for Enzyme Immunoassay
Epitope
pSer1177
52
25
24
22
21
18
16
16
14
14
14
14
9
9
9
8
6
6
6
5
5
5
5
5
4
4
4
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivity
Human, Mouse (Murine), Rat (Rattus)
394
223
209
37
34
33
11
11
2
2
2
2
2
1
1
1
1
Host
Rabbit
424
42
Clonality
Polyclonal
Conjugate
This ENOS antibody is un-conjugated
28
25
17
12
7
7
6
6
6
6
6
6
6
6
6
Application
Immunofluorescence (IF), Immunohistochemistry (IHC)
297
178
72
68
62
59
24
24
23
19
11
9
5
2
2
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Immunogen Peptide sequence around phosphorylation site of pSer1177 (T-Q-S (p) -F-S) derived from Human eNOS. Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates.
Isotype IgG
Specificity The antibody detects endogenous level of eNOS only when phosphorylated at serine 1177.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific phosphopeptide. The antibody against non-phosphopeptide was removedby chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Alternative Name eNOS (NOS3 Antibody Abstract)
Background Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.
Molecular Weight 140 kDa
NCBI Accession NP_000594
UniProt P29474
Research Area Cancer, Enzymes, Metabolism, Inflammation
Pathways ACE Inhibitor Pathway
Application Notes Immunohistochemistry: 1:50-1:100
Immunofluorescence: 1:100-1:200
Restrictions For Research Use only
Format Liquid
Concentration 1 mg/mL
Buffer Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
Background publications Thomas, Chen, Keaney: "Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway." in: The Journal of biological chemistry, Vol. 277, Issue 8, pp. 6017-24, 2002 (PubMed).

Harris, Ju, Venema, Liang, Zou, Michell, Chen, Kemp, Venema: "Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation." in: The Journal of biological chemistry, Vol. 276, Issue 19, pp. 16587-91, 2001 (PubMed).

Wadman: "GM advisory panel is slanted, say critics." in: Nature, Vol. 399, Issue 6731, pp. 7, 1999 (PubMed).